Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
The number of patients with gastroesophageal problems taking proton pump inhibitors (PPIs) is increasing. Several studies suggested a possible association between PPIs and fracture risk, especially hip fractures, but the relationship remains contentious. This review aimed to investigate the longitudinal studies published in the last five years on the relationship between PPIs and fracture risk. The mechanism underlying this relationship was also explored. Overall, PPIs were positively associated with elevated fracture risk in multiple studies (n = 14), although some studies reported no significant relationship (n = 4). Increased gastrin production and hypochlorhydria are the two main mechanisms that affect bone remodeling, mineral absorption, and muscle strength, contributing to increased fracture risk among PPI users. As a conclusion, there is a potential relationship between PPIs and fracture risks. Therefore, patients on long-term PPI treatment should pay attention to bone health status and consider prophylaxis to decrease fracture risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Proton pump inhibitor treatment for acute peptic ulcer bleeding
Leontiadis, G. I., McIntyre, L., Sharma, V. K., & Howden, C. W. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002094.pub2 · Cited by 232
RetractedAn estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Hip fractures in the elderly: A world-wide projection
Cooper, C., Campion, G., & Melton, L. J. (1992) · Osteoporosis International · doi:10.1007/bf01623184 · Cited by 3,213
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1449 · Cited by 1,408
HADJIDAKIS, D. J., & ANDROULAKIS, I. I. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.035 · Cited by 1,360 · cited 1×
“The optimal balance between these two biological processes helps maintain bone microstructure [110].”
BackgroundB Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review
Kennedy, D. (2016) · Nutrients · doi:10.3390/nu8020068 · Cited by 1,055
Freedberg, D. E., Kim, L. S., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 891
Mortality and morbidity after hip fractures.
Keene, G. S., Parker, M. J., & Pryor, G. A. (1993) · BMJ · doi:10.1136/bmj.307.6914.1248 · Cited by 876
Guidelines for Prevention of NSAID-Related Ulcer Complications
and the Practice Parameters Committee of the American College of Gastroenterology, Lanza, F. L., Chan, F. K. L., & Quigley, E. M. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.115 · Cited by 790
Granacher, U., Gollhofer, A., Hortobágyi, T., Kressig, R. W., & Muehlbauer, T. (2013) · Sports Medicine · doi:10.1007/s40279-013-0041-1 · Cited by 625
Mortality and cause of death in hip fracture patients aged 65 or older - a population-based study
Panula, J., Pihlajamäki, H., Mattila, V. M., Jaatinen, P., Vahlberg, T., Aarnio, P., & Kivelä, S.-L. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-105 · Cited by 597 · cited 1×
“The risk of mortality in hip fracture patients is threefold higher than the general population [24].”
BackgroundMagnesium and Osteoporosis: Current State of Knowledge and Future Research Directions
Castiglioni, S., Cazzaniga, A., Albisetti, W., & Maier, J. (2013) · Nutrients · doi:10.3390/nu5083022 · Cited by 540 · cited 1×
“Magnesium deficiency is detrimental to bone by inducing formation of large hydroxyapatite crystals which decrease bone stiffness, decrease osteoblastic activity, and increase the number of osteoclasts, as well as promoting inflammation and oxidative stress [85].”
BackgroundO’Connell, M. B., Madden, D. M., Murray, A. M., Heaney, R. P., & Kerzner, L. J. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.007 · Cited by 405 · cited 1×
“They included 18 women with a mean age of 76 ± 7 years and a mean weight of 61 ± 7 kg [84].”
BackgroundUndertreatment of Osteoporosis in Men With Hip Fracture
Kiebzak, G. M., Beinart, G. A., Perser, K., Ambrose, C. G., Siff, S. J., & Heggeness, M. H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2217 · Cited by 384
Hersey, S. J., & Sachs, G. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.1.155 · Cited by 360 · cited 1×
“The ECLCs produce histamine to further stimulate parietal cells [52].”
BackgroundOsteoporosis: the role of micronutrients
Nieves, J. W. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.1232 · Cited by 343 · cited 1×
“Calcium is indispensable in maintaining bone microstructure [79,80].”
BackgroundDisorders Involving Calcium, Phosphorus, and Magnesium
Moe, S. M. (2008) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2008.01.007 · Cited by 332 · cited 1×
“This process, which involves bone resorption, deteriorates the bone microstructure and strength, and increases the fracture risk [83].”
BackgroundpH dependence of acid secretion and gastrin release in normal and ulcer subjects.
Walsh, J. H., Richardson, C. T., & Fordtran, J. S. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107952 · Cited by 331
Overutilization of proton-pump inhibitors: what the clinician needs to know
Heidelbaugh, J. J., Kim, A. H., Chang, R., & Walker, P. C. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12437358 · Cited by 327
Hasserius, R., Karlsson, M. K., Nilsson, B. E., Not Available, I., & Johnell, O. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1316-9 · Cited by 313
Osteoporosis: Definition and Clinical Presentation
Glaser, D. L., & Kaplan, F. S. (1997) · Spine · doi:10.1097/00007632-199712151-00003 · Cited by 306
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal
Savarino, V., Dulbecco, P., de Bortoli, N., Ottonello, A., & Savarino, E. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.10.007 · Cited by 270 · cited 1×
“Other than that, PPIs were one of the most frequently sold over-the-counter drug with $13 billion of global market value [13].”
BackgroundOmeprazole Therapy Causes Malabsorption of Cyanocobalamin (Vitamin B12)
Marcuard, S. P., Albernaz, L., & Khazanie, P. G. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00006 · Cited by 251 · cited 1×
“Therefore, they concluded that the decreased absorption of vitamin B12 was in a dose-dependent manner [99].”
BackgroundValuck, R. J., & Ruscin, J. M. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.08.015 · Cited by 239 · cited 2×
“Other studies found that the absorption of vitamin B was negatively affected by PPIs [93,94].”
BackgroundEffect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans
Mizunashi, K., Furukawa, Y., Katano, K., & Abe, K. (1993) · Calcified Tissue International · doi:10.1007/bf01352010 · Cited by 238 · cited 2×
“Exposure of PPI among Japanese patients with gastric ulcer (n = 19; aged 67 ± 13 years) led to a 28% increase in the mean PTH level and serum bone turnover markers (serum osteocalcin and alkaline phosphatase), and a decrease in the renal excretion of calcium and hydroxyproline [66].”
BackgroundPhysiology of the Calcium-Parathyroid Hormone-Vitamin D Axis
Goltzman, D., Mannstadt, M., & Marcocci, C. (2018) · Frontiers of Hormone Research · doi:10.1159/000486060 · Cited by 216 · cited 1×
“The reduction in circulating calcium promotes the parathyroid gland to secrete more PTH to mobilize calcium storage in the bone [81,82].”
BackgroundVergara, M., Catalán, M., Gisbert, J. P., & Calvet, X. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02444.x · Cited by 215
The Association of Race, Gender, and Comorbidity With Mortality and Function After Hip Fracture
Penrod, J. D., Litke, A., Hawkes, W. G., Magaziner, J., Doucette, J. T., Koval, K. J., Silberzweig, S. B., Egol, K. A., & Siu, A. L. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.8.867 · Cited by 207
Gastric Acid, Calcium Absorption, and Their Impact on Bone Health
Kopic, S., & Geibel, J. P. (2013) · Physiological Reviews · doi:10.1152/physrev.00015.2012 · Cited by 176
Welage, L. S., & Berardi, R. R. (2000) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31036-1 · Cited by 168
Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding
Leontiadis, G. I., Sharma, V. K., & Howden, C. W. (2005) · BMJ · doi:10.1136/bmj.38356.641134.8f · Cited by 164
Fraser, L.-A., Leslie, W. D., Targownik, L. E., Παπαϊωάννου, Α., & Adachi, J. D. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2112-9 · Cited by 158 · cited 3×
“6 years) after using PPIs for a decade [34].”
BackgroundInfluentialB Vitamins, Homocysteine and Bone Health
Fratoni, V., & Brandi, M. L. (2015) · Nutrients · doi:10.3390/nu7042176 · Cited by 155 · cited 1×
“However, there is a paucity of studies which consider the interrelation among PPIs, vitamin B level, and fracture risk together [95,101,104].”
BackgroundParathyroid Hormone Temporal Effects on Bone Formation and Resorption
Kroll, M. H. (2000) · Bulletin of Mathematical Biology · doi:10.1006/bulm.1999.0146 · Cited by 145 · cited 1×
“The reduction in circulating calcium promotes the parathyroid gland to secrete more PTH to mobilize calcium storage in the bone [81,82].”
BackgroundLewis, J. R., Barre, D., Zhu, K., Ivey, K. L., Lim, E. M., Hughes, J., & Prince, R. L. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2279 · Cited by 127 · cited 3×
“to suggest that patients on high-dose and longer-term PPI had an increased fall risk [42].”
BackgroundHerrmann, M., Peter Schmidt, J., Umanskaya, N., Wagner, A., Taban-Shomal, O., Widmann, T., Colaianni, G., Wildemann, B., & Herrmann, W. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.362 · Cited by 124 · cited 2×
“This will reduce the quality of the skeletal collagenous matrix [95].”
BackgroundUse of proton pump inhibitors is associated with fractures in young adults: a population-based study
Freedberg, D. E., Haynes, K., Denburg, M., Zemel, B. S., Leonard, M. B., Abrams, J. A., & Yang, Y. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3168-0 · Cited by 124 · cited 4×
“However, there was no significant relationship between PPI use and fracture risk in children in terms of cumulative exposure manner [41].”
BackgroundInfluentialDuplan, M. B., Baroukh, B., Dy, M., de Vernejoul, M. C., & Jl, S. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080871 · Cited by 117 · cited 1×
“Since histamine could increase the differentiation of osteoclast precursors [63], the effects of hypersecretion of histamine due to ECLC hyperplasia on bone should be a concern.”
BackgroundB-Vitamins and Bone Health–A Review of the Current Evidence
Dai, Z., & Koh, W. (2015) · Nutrients · doi:10.3390/nu7053322 · Cited by 115 · cited 3×
“vitamin B2, B6, and folate and bone health remains heterogenous in human studies [101].”
BackgroundCosta‐Rodrigues, J., Reis, S., Teixeira, S., Lopes, S., & Fernandes, M. H. (2013) · FEBS Journal · doi:10.1111/febs.12478 · Cited by 114 · cited 4×
“This was accompanied by a reduction in the markers related to resorptive activity, such as c-myc, c-src, TRAP, and cathepsin K, when the concentration of the PPI was ≥10−5 M [112].”
BackgroundMethodInfluentialSanduleanu, Stridsberg, Jonkers, Hameeteman, Biemond, Lundqvist, Lamers, & Stockbrügger (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00466.x · Cited by 111
Jung, S. B., Nagaraja, V., Kapur, A., & Eslick, G. D. (2015) · Internal Medicine Journal · doi:10.1111/imj.12697 · Cited by 99
Alzheimer’s Disease and Risk of Hip Fracture: A Meta-Analysis Study
Zhao, Y., Shen, L., & Ji, H.-F. (2012) · The Scientific World Journal · doi:10.1100/2012/872173 · Cited by 86
Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children
Wang, Y.-H., Wintzell, V., Ludvigsson, J. F., Svanström, H., & Pasternak, B. (2020) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2020.0007 · Cited by 84
Chronic Proton Pump Inihibitor Therapy and Calcium Metabolism
Yang, Y. (2012) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0290-4 · Cited by 81
Pang, M. Y. C., & Eng, J. J. (2005) · Bone · doi:10.1016/j.bone.2005.03.009 · Cited by 79
van der Hoorn, M. M. C., Tett, S. E., de Vries, O. J., Dobson, A. J., & Peeters, G. M. E. E. (2015) · Bone · doi:10.1016/j.bone.2015.08.024 · Cited by 75 · cited 3×
“[36] Design: prospective cohort, mean follow-up period: 6.”
BackgroundSurgery for Hip Fracture Yields Societal Benefits That Exceed the Direct Medical Costs
Gu, Q., Koenig, L., Mather, R. C. “., & Tongue, J. R. (2014) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-014-3820-6 · Cited by 72 · cited 1×
“In the United States, the estimated age-weighted and lifetime savings for surgical treatment of hip fractures was more than United States dollar (USD) 65,000 for a patient [25].”
BackgroundParathyroid hormone-related protein (PTHrP) and hypercalcaemia
Grill, V., Rankin, W. A., & Martin, T. J. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10130-7 · Cited by 62
Proton-pump inhibitor use and hip fractures in men: a population-based case-control study
Adams, A. L., Black, M. H., Zhang, J. L., Shi, J. M., & Jacobsen, S. J. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.01.004 · Cited by 62 · cited 6×
“5 months had an increased hip fracture risk [32].”
BackgroundInfluentialThe Relationship Between Proton Pump Inhibitor Adherence and Fracture Risk in the Elderly
Ding, J., Heller, D. A., Ahern, F. M., & Brown, T. V. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9855-6 · Cited by 60 · cited 4×
“The relationship between PPIs and fracture risk in the elderly is debatable [30,37,39].”
BackgroundMethodInfluentialLin, S., Yang, S.-H., Liang, C. C., & Huang, H. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4262-2 · Cited by 60 · cited 6×
“Two studies performed in Taiwan used the National Health Insurance Research Database to examine the association between PPIs and fracture risk in GERD and stroke patients [33,47].”
BackgroundMethodResultInfluentialProton Pump Inhibitors and Risk of Bone Fractures
Leontiadis, G. I., & Moayyedi, P. (2014) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0030-y · Cited by 58
Bone health: the role of micronutrients
Lanham-New, S. A. (1999) · British Medical Bulletin · doi:10.1258/0007142991902501 · Cited by 56 · cited 1×
“Calcium is indispensable in maintaining bone microstructure [79,80].”
BackgroundLee, J., Youn, K.-E., Choi, N., Lee, J., Kang, D. Y., Song, H. J., & Park, B. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-012-0722-9 · Cited by 55 · cited 3×
“[43] Design: case-control Subjects: Korean elderly ≥65 (mean: 77.”
BackgroundInfluentialLee, L., Ramos-Álvarez, I., Ito, T., & Jensen, R. T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205128 · Cited by 55
Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016
Daniels, B. J., Pearson, S., Buckley, N. A., Bruno, C., & Zoëga, H. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820913743 · Cited by 55
Vitamin B12 Deficiency in Relation to Functional Disabilities
Oberlin, B. S., Tangney, C., Gustashaw, K. A. R., & Rasmussen, H. E. (2013) · Nutrients · doi:10.3390/nu5114462 · Cited by 54
Moberg, L., Nilsson, P. M., Samsioe, G., & Borgfeldt, C. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.05.019 · Cited by 53 · cited 2×
“Several studies focused on the relationship between PPIs and fracture among postmenopausal women [36,40,42].”
BackgroundDietary B vitamin intake and risk of hip fracture: the Singapore Chinese Health Study
Dai, Z., Wang, R., Ang, L. W., Yuan, J., & Koh, W.-P. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2233-1 · Cited by 50 · cited 1×
“8 years) found no significant effect of vitamin B3 on bone [102].”
BackgroundGastrin secretion from human antral G cells in culture
Campos, R. V., Buchan, A. M. J., Meloche, R. M., Pederson, R. A., Kwok, Y. N., & Coy, D. H. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91226-v · Cited by 50
Hinson, A. M., Wilkerson, B. M., Rothman‐Fitts, I., Riggs, A. T., Stack, B. C., & Bodenner, D. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13661 · Cited by 48
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa
Rindi, G., Fiocca, R., Morocutti, A., Jacobs, A., Miller, N., & Thjodleifsson, B. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200505000-00013 · Cited by 47 · cited 1×
“001 for gastrin effect) was found [58].”
Proton pump inhibitors use and change in bone mineral density
Arj, A., Zadeh, M. R., Yavari, M., Akbari, H., Zamani, B., & Asemi, Z. (2016) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12866 · Cited by 46
Role of parathyroid hormone-related peptide and Indian hedgehog in skeletal development
Jüppner, H. (2000) · Pediatric Nephrology · doi:10.1007/s004670000343 · Cited by 45
Soriano, L. C., Ruigómez, A., Johansson, S., & Rodríguez, L. A. G. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1410 · Cited by 43 · cited 3×
“In this study, the subjects included were already at high risk for fracture, as the majority were women aged ≥60 years old [35].”
BackgroundInfluentialChen, C.-H., Lin, C., & Kao, C. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3510-1 · Cited by 40 · cited 6×
“Two studies performed in Taiwan used the National Health Insurance Research Database to examine the association between PPIs and fracture risk in GERD and stroke patients [33,47].”
BackgroundMethodResultInfluentialSimple Balance and Mobility Tests Can Assess Falls Risk When Cognition Is Impaired
McMichael, K. A., Bilt, J. V., Lavery, L., Rodríguez, E., & Ganguli, M. (2008) · Geriatric Nursing · doi:10.1016/j.gerinurse.2007.10.016 · Cited by 40
Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts
Chun, ○. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000537 · Cited by 36 · cited 4×
“Omeprazole was noted to increase the ratio of osteoprotegerin to receptor activator of nuclear factor kappa-Β ligand in an osteoblast (MC3T3-E1) culture when 4 μg/mL omeprazole was applied [111].”
BackgroundInfluentialUse of proton pump inhibitors and risk of fragility hip fracture in a Mediterranean region
Reyes, C., Formiga, F., Coderch, M., Hoyo, J., Férriz, G., Casanovas, J., Monteserín, R., Brotons, C., Rojas, M., & Moral, I. (2012) · Bone · doi:10.1016/j.bone.2012.09.028 · Cited by 34
The relationship between long-term proton pump inhibitor therapy and skeletal frailty
Lau, A. N., Tomizza, M. A., Wong‐Pack, M., Παπαϊωάννου, Α., & Adachi, J. D. (2015) · Endocrine · doi:10.1007/s12020-015-0576-z · Cited by 31
Torvinen‐Kiiskinen, S., Tolppanen, A., Koponen, M., Tanskanen, A. J., Tiihonen, J., Hartikainen, S. A., & Taipale, H. T. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14589 · Cited by 30 · cited 5×
“This study reported a reliable documentation system on drug use period and the use of representative nationwide data [44].”
BackgroundMethodInfluentialProton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients
Douwes, R. M., Neto, A. W. G., Schutten, J. C., van den Berg, E., de Borst, M. H., Berger, S. P., Touw, D. J., Hak, E., Blokzijl, H., Navis, G. J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122162 · Cited by 29
Proton pump inhibitor use and the risk of fractures among an older adult cohort
Harding, B. N., Weiss, N. S., Walker, R. L., Larson, E. B., & Dublin, S. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4406 · Cited by 27
Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients
Lenihan, C. R., Nair, S. S., Vangala, C., Ramanathan, V., Montez‐Rath, M. E., & Winkelmayer, W. C. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.09.019 · Cited by 25 · cited 4×
“4 for control) but a clear frequency-dependent relationship was not observed [46].”
BackgroundInfluentialGastrin induces parathyroid hormone-like hormone expression in gastric parietal cells
Menhali, A. A., Keeley, T. M., Demitrack, E. S., & Samuelson, L. C. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00366.2016 · Cited by 23 · cited 2×
“On the other hand, parathyroid hormone-related peptide (PTHrP) was shown to be regulated by gastrin [71].”
BackgroundPrevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease
Hughes, J., Chiu, D. Y. Y., Kalra, P. A., & Green, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197400 · Cited by 22
Vangala, C., Niu, J., Lenihan, C. R., Mitch, W. E., Navaneethan, S. D., & Winkelmayer, W. C. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02190218 · Cited by 21 · cited 3×
“In terms of cumulative exposure, patients who took PPI < 20%, 20% ≤ x < 80%, and ≥80% of the time for three years were all at risk for hip fracture [45].”
BackgroundThe effects of oral rabeprazole on endocrine and gastric secretory function in healthy volunteers
Dammann, Burkhardt, & Wolf (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00545.x · Cited by 21 · cited 3×
“, 12 healthy young men were treated with oral rabeprazole (20 mg per day for 14 days), but no clinically relevant effect on T3, T4, and PTH level was observed [48].”
BackgroundProton pump inhibitors therapy and the risk of hip fracture in older people in Taiwan
Lai, S., Lin, C.-H., Lin, C., et al. (2018) · European Geriatric Medicine · doi:10.1007/s41999-017-0022-2 · Cited by 18 · cited 4×
“The relationship between PPIs and fracture risk in the elderly is debatable [30,37,39].”
BackgroundInfluentialRisk of fall in patients taking proton pump inhibitors: a meta-analysis
Lapumnuaypol, K., Thongprayoon, C., Wijarnpreecha, K., Tiu, A. C., & Cheungpasitporn, W. (2018) · QJM · doi:10.1093/qjmed/hcy245 · Cited by 16
McGowan, B., Bennett, K., & Barry, M. G. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1972 · Cited by 16 · cited 1×
“Overall, PPIs account for 95% of acid-suppressing drugs prescription due to their effectiveness [10].”
BackgroundCalcium, proton pump inhibitors, and fracture risk
Sugiyama, T., Torio, T., Miyajima, T., Kim, Y. T., & Oda, H. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3403-8 · Cited by 13
Parathyroid hormone-related peptide and bone: pathological and physiological aspects
Inoue, D., & Matsumoto, T. (2000) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(00)80008-6 · Cited by 13
Proton pump inhibitors use in hemodialysis patients and serum magnesium levels.
Erdem, E. (2015) · PubMed Central · Cited by 13
Proton-pump inhibitor therapy and vitamin B12 status in an inpatient hospital setting
Hartman, B., Donnelly-Vanderloo, M., Watson, T. D., O’Connor, C. P., & Madill, J. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0020 · Cited by 13
Nishi, T., Makuuchi, H., & Weinstein, W. M. (2005) · PubMed · Cited by 12
(2012) · Europe PMC (PubMed Central) · Cited by 10
Nakamura, S., Watanabe, H., Yokota, T., Matsui, H., Onji, M., & Maeyama, K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00080-7 · Cited by 9
Cited by
Pathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people
Barnsley, J., Buckland, G., Chan, P. E., Ong, A., Ramos, A. S., Baxter, M., Laskou, F., Dennison, E. M., Cooper, C., & Patel, H. P. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01817-y · Cited by 199
Metadata
- Authors
- Thong, B. K. S., Ima-Nirwana, S., & Chin, K.-Y.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2019-05-05
- Volume
- 16
- Issue
- 9
- Pages
- 1571
- ISSN
- 1660-4601 (ISSN-L)
- OpenAlex
- W2943411653
- Cited by
- 159
- References
- 90
- FWCI
- 15.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.